Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Clinical trial NCT02860286 · COMPLETED
Trial details
- NCT number
- NCT02860286
- Sponsor
- Epizyme, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-06-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.